期刊文献+

脑钠肽和内皮素在冠状动脉旁路移植术中的变化及意义 被引量:4

Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting
暂未订购
导出
摘要 目的观察氨基末端B型脑钠肽(Nt-proBNP)和大内皮素(bigET)在冠状动脉旁路移植术(CABG)前后的变化及其对术后近期并发症的预测价值。方法分析47例常规体外循环冠状动脉旁路移植术(CCABG)和43例非体外循环冠状动脉旁路移植术(OPCAB)患者术前和术后24hNt-proBNP、bigET水平变化,及其对术后近期并发症的预测因子。结果1术后24hCCABG和OPCAB两组Nt-proBNP和bigET均明显升高,CCABG组Nt-proBNP由术前(1083.5±717.9)pmol/L升到术后24h(1579.2±719.7)pmol/L(t=-4.30,P〈0.01),bigET由术前(1.10±1.82)pmol/L升到术后24h(1.68±1.73)pmol/L(t=-5.35,P〈0.01);OPCAB组Nt-proBNP由术前(999.6±843.6)pmol/L升到术后24h(1460.8±830.0)pmol/L(t=-4.20,P〈0.01),bigET由术前(1.35±1.65)pmol/L升到术后24h(1.73±1.50)pmol/L(t=-2.46,P=0.018)。2术前Nt-proBNP水平与左室射血分数(LVEF)呈负相关(r=-0.43,P〈0.001)。3经单变量和多变量Logistic回归分析,LVEF相对比值比(OR)=1.045,95%可信区间(CI)为0.999~1.092,P=0.050、术后24h Nt-proBNP(OR=0.990,95%CI为0.999-1.000,P=0.014)水平是术后心力衰竭、低心排、围手术期心肌梗死、死亡、脑梗死的独立预测因子。经受试者工作特征曲线(ROC)分析术后24h Nt-proBNP〉1174.41pmol/L时,曲线下面积为0.698,95%CI为0.585-0.811,P〈0.003,敏感性为88.9%,特异性为57.1%,可预测近期并发症。结论CABG术后Nt-proBNP、bigET明显升高;LVEF、术后24h Nt-proBNP水平可预测术后近期并发症的发生。 Objective To examine the change in N-terminal pro-brain natriuretic peptide (Nt-proBNP) and big endothelin (bigET) in patients undergoing coronary artery bypass grafting (CABG), and to evaluate their value in predicting postoperative mortality and complication. Methods Forty-seven patients undergoing coronary artery bypass grafting under on-pump(CCABG) and 43 patients undergoing off-pump bypass(OPCAB) were included for study. The levels of Nt-proBNP and bigET were determined before and 24 hours after operation in all patients. Results ①There were no differences between two groups. The serum levels of Nt-proBNP and bigET increased significantly 24 hours after operation. Compared with those before operation, Nt-proBNP (1 083.5±717.9)pmol/L in CCABG group was increased (1 579.2±719.7)pmol/L, t=-4.30, P〈0.01, bigET was increased from (1.10±1.82 ) pmol/L to (1.68±1.73) pmol/L (t=-5.35, P〈0.01) 24 hours after operation; Nt-proBNP (999.6±843.6) pmol/L in OPCAB group was increased (1 460.8±830.0) pmol/L, t=-4.20, P〈0.01, bigET was increased from (1.35±1.65) pmol/L to (1.73±1.50) pmol/L (t=-2.46, P=0.018) 24 hours after operation. ②The level of Nt-proBNP before operation was showed to be negatively correlated with left ventricular ejection fraction (LVEF) (r=-0.43, P〈0.001). ③By univariate and multivariate Logistic regression analysis, the association of clinical variable with postoperative complication was assessed. Multivariable predictors,including the level of LVEF (OR=1.045, 95%CI:0.999-1.092, P=0.050) and Nt-proBNP 24 hours after operation (OR=0.990, 95%CI:0.999-1.000,P=0.014), were significantly associated with a higher postoperative mortality, lower cardiac output, and higher incidence of myocardial infarction and congestive heart failure. Receiver operating characteristic curves (ROC) for Nt-proBNP 24 hours after operation was valid for the prediction of postoperative complication, and the area under the curve was 0.698 (95%CI:0.585-0.811, P〈0.003), sensitivity and specificity were 88.9% and 57.1%, respectively. Conclusion Significant increase in Nt-proBNP and ET is found after CABG. BNP and LVEF are showed to be risk factors for postoperative complications in patients undergoing CABG.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2007年第11期667-670,共4页 Chinese Critical Care Medicine
关键词 冠状动脉旁路移植术 氨基末端B型脑钠肽 大内皮素 coronary artery bypass grafting N-terminal pro-brain natriuretic peptide big endothelin
  • 相关文献

参考文献10

  • 1Berendes E.Schmidt C,Van Aken H,et al. A- type and B- type natriuretic peptides in cardiac surgical procedures[J]. Anesth Analg,2004.98(1) :11 - 19.
  • 2Ndrepepa G,Braun S,Mehilli J .et al. Plasma levels of N -terminal pro - brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation.angiographic severity. and left ventricular ejection fraction[J]. Am J Cardiol, 2005, 95(5):553 - 557.
  • 3汪芳,王莉,边文彦,顼志敏,李一石.慢性心力衰竭急性发作患者N端前脑钠素水平的变化[J].中国危重病急救医学,2006,18(4):195-198. 被引量:21
  • 4Watanabe M. Egi K, Hasegawa S. et al. Slgnificance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting[J]. Surg Today,2003.33(9),671 - 673.
  • 5温绍君,王金城,张忱,张文,文杰,王佐广,刘洁琳,周其文.冠脉搭桥围手术期肿瘤坏死因子和内皮素的动态变化及意义[J].中华医学杂志,2001,81(23):1450-1452. 被引量:9
  • 6Hedman A, Larsson P T, Alam M, et al. CRP, IL - 6 and endothelin- 1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early grafl occlusion and late cardiovascular events[J]? Int J Cardiol.2007.120(1):108- 114.
  • 7Mullani M M. lkonomidis J S. Kim P Y. et al. Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg.2005.129(3) :584 - 590.
  • 8Shimada Y. Yaku H. Shuntoh K. et al. Impact of myocardial angiotensin converting enzyme activity on coronary vascular resistance and serum brain natriuretic peptide peptide concentration in coronary bypass surgery[J]. Circ J, 2003, 67 (5): 379 - 383.
  • 9Provenchere S. Berroeta C. Reynaud C. et al. Plasma brain natriuretic peptide and cardiac troponin Ⅰ concentrations after adult cardiac surygery; association with postoperative cardiac dysfunction and 1 -year mortality[J]. Crit Care Med, 2006, 34 (4) :995 - 1000.
  • 10Kerbaul F, Giorgi R, Oddoze C. el al. High concentrations of N - BNP are related to non - infectious severe SIRS associated with cardiovascular dysfunction occurring after off - pump coronary artery surgery [J]. Br J Anaesth,2004.93(5):639- 644.

二级参考文献13

  • 1李文强,李艳,魏捷,李国草,李庚山.扩张型心肌病家兔血浆脑钠肽水平的改变及其意义[J].中国危重病急救医学,2005,17(3):161-164. 被引量:16
  • 2李永健,王林,陈康寅,陈元禄,蔡金荣,周丽娟.N-末端脑钠素原与心钠素对冠心病慢性心力衰竭诊断及预后判断价值的比较研究[J].中国危重病急救医学,2005,17(9):544-547. 被引量:22
  • 3Jansen N J G,Ann Thorac,1992年,54卷,744页
  • 4Francis G S,Benedict C,Johnstone D E,et al.Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure:a substudy of the studies of left ventricular dysfunction (SOLVD)[J].Circulation,1990,82:1724-1729.
  • 5Richards A M,Nicholls M G,Yandle T G,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin:new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction[J].Circulation,1998,97:1921-1929.
  • 6Shi X,Xu G,Xia T,et al.N-terminal-pro-Btype natriuretic peptide (NT-ProBNP):reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure[J].Clin Chim Acta,2005,360:122-127.
  • 7Richards A M,Doughty R,Nicholls M G,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenonedullin:prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction,Australia-New Zealand heart failure group[J].J Am Coll Cardiol,2001,37:1781-1787.
  • 8Knebel F,Schimke I,Pliet K,et al.NT-proBNP in acute heart failure:correlation with invasively measured hemodynamic parameters during recompensation[J].J Card Fail,2005,11(5 Suppl):s38-s41.
  • 9Hall C.NT-proBNP:the mechanism behind the marker[J].J Card Fail,2005,11(5 Suppl):S81-83.
  • 10Kellett J.The prediction of in-hospital mortality by amino terminal pro-brain natriuretic peptide (NTproBNP) levels and other independent variables in acutely ill patients with suspected heart disease[J].Eur J Intern Med,2005,16:195-199.

共引文献28

同被引文献33

  • 1刘艳丽,陶新智,伍伟锋.脑利钠肽与心房颤动[J].心血管病学进展,2005,26(1):40-42. 被引量:3
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].高血压杂志,2004,12(6):483-486. 被引量:368
  • 3Colucci WS,Elkayam U,Horton DP,et al.Intravenous nesiri 2tide,a natriuretic peptide,in the treatment of decompensated congestive heart failure[J].N Engl J Med,2000,343:246-253.
  • 4James SK,Lindahl B,SiegbahnA,et al.Terminal pro-brain natriuretie peptideand other riskmlLrkers forthezeparate prediction ofmortality and subsequent tmyocardial infarctionin patients with unstable coronaryartery disease:a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy[J].Circulation,2003,108(3):275.
  • 5Beck-da-Silva L,Rohda LE,Goldraich L,et al.Clinical findings,natriuretic peptides,and echocardiography:integrating tools to optimize heart failure management[J].Congest Heart Fail,2007,13(3):158-163.
  • 6Amalia H,Kostas T,Marina T,et al.BNP plasma levels or left atrial dimension for the prediction of paroxysmal atrial fibrillation in subjects with essential hypertension[J].Am Heart J,2004,17(4pt2):228-232.
  • 7Aranki S F, Shaw D P, Adams D H, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996, 94(3): 390-397.
  • 8Hutfless R, Kazanegra R, Madani M, et al. Utility of b-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004, 43(10): 1873-1879.
  • 9Sachdeva A, Horwich T B, Fonarow G C. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol. 2010, 106(6): 830-835.
  • 10Fellahi J L, Daccache G, Rubes D, et al. Does preoperative b-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard european system for cardiac operative risk evaluation after cardiac surgery'? J Cardiothorac Vasc Anesth. 2011, 25(2): 256-262.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部